Skip to content

Thinking of buying a pharma stock?

How to read a pharma stock

Medicines for India and the world, with regulators watching every factory.

How they make money

  1. Make generic medicines: copies of drugs whose patents have run out.

  2. Sell them in India and export them, often to the US.

  3. Spend on research to launch new medicines before rivals do.

Numbers to check

Tap any number for a full lesson with pictures.

Practice: Neem Pharma's numbers

Neem Pharma is a made-up company that makes and exports generic medicines. Here's how its key numbers read against the rough guides.

Neem Pharma's key numbers with a rough-guide verdict for each
NumberNeem PharmaRough guide says
Sales growth11.1%Steady
Operating margin20%Decent
R&D spend7%Moderate
ROCE16.7%Good
Debt-to-equity0.2xLow
P/E30xMiddle

For a real company, check each number over at least five years and against its closest rivals. One year alone can mislead.

Also look at

  • USFDA inspections: a warning letter can stop a factory from selling to the US.
  • US price erosion: generic prices fall as more rivals launch the same drug.
  • Approvals in the pipeline: new products waiting for regulators' go-ahead.

Red flags

  • A USFDA warning letter or import alert at a major factory.
  • Most of the profit coming from one drug that's about to face competition.
  • Research spending cut to prop up profit.

Numbers that mislead here

Other sectors

All lessons

For learning only. Example companies are made up, and the rough guides are rules of thumb, not targets. Nothing here is advice to buy or sell any stock.